WorldCat Identities

Peto, Richard 1943-

Works: 23 works in 82 publications in 5 languages and 1,498 library holdings
Genres: Conference papers and proceedings  Interviews  Documentary television programs  Biography 
Roles: Editor, Author, Other, Thesis advisor
Classifications: RC268.5, 614.5999
Publication Timeline
Most widely held works by Richard Peto
The causes of cancer : quantitative estimates of avoidable risks of cancer in the United States today by Richard Doll( Book )

19 editions published between 1981 and 1991 in 3 languages and held by 417 WorldCat member libraries worldwide

Mortality from smoking in developed countries, 1950-2000 : indirect estimates from national vital statistics by Richard Peto( Book )

9 editions published in 1994 in English and held by 371 WorldCat member libraries worldwide

Quantification of occupational cancer by Banbury Center( Book )

7 editions published in 1981 in English and held by 237 WorldCat member libraries worldwide

Viral etiology of cervical cancer by Banbury Center( Book )

9 editions published in 1986 in English and held by 183 WorldCat member libraries worldwide

Le cause del cancro : prospettive di prevenzione by Richard Doll( Book )

3 editions published in 1983 in Italian and held by 5 WorldCat member libraries worldwide

Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments( Book )

1 edition published in 1980 in English and held by 4 WorldCat member libraries worldwide

Atlas: adjuvant tamoxifen longer against shorter by Richard Peto( Book )

6 editions published between 1997 and 2000 in English and held by 4 WorldCat member libraries worldwide

Worldwide, more than 1 million women with early breast cancer take adjuvant tamoxifen. However, there is uncertainty about the optimal duration of treatment. ATLAS is a major international trial which will help to assess this optimal duration reliably. If ATLAS demonstrates an additional advantage from longer treatment, then several thousands of deaths could be avoided each year if women are treated accordingly. The ATLAS collaboration continues to achieve its interim and overall objectives. Since 1 October 1995, the infrastructure for the trial has been established in several hundred hospitals in more than 20 countries worldwide; collaborators' meetings have been organized in most countries; free tamoxifen has been negotiated, funding for its supply and distribution secured, and 2 cycles of tamoxifen have already been distributed; by 1/10/97 232 hospitals had ethical approval, with the remaining hospitals in the process of obtaining approval; randomization had started in 146 hospitals, with about 1600 patients already randomized. The first annual follow-up took place in January 1997 on all patients randomized in the study. The independent Data Monitoring Committee had its second meeting in March 1997 and endorsed the continuing importance of ATLAS, including its design and implementation. The first meeting of the Steering Committee was held in Oxford in September 1997, and ATLAS continues to have a high profile at important international breast cancer meetings
The Natural history of chronic bronchitis and emphysema : an eight-year study of early chronic obstructive lung disease in working men in London( Book )

1 edition published in 1976 in English and held by 2 WorldCat member libraries worldwide

Demokracja jest zdrowsza : cud zdrowotny nad Wisłą by W Zatoński( Book )

1 edition published in 2002 in Polish and held by 2 WorldCat member libraries worldwide

Heroes and villains( Visual )

1 edition published in 1998 in English and held by 1 WorldCat member library worldwide

Breast cancer in the 1950s was treated by radical surgery; both the disease and its treatment inspired fear and silence. Only after much opposition from the medical establishment did the less radical alternative of lumpectomy gradually become available. For testicular cancer, too, prospects improved with the 1960s discovery of a platinum compound treatment. By 1976 Hodgkins disease and childhood leukaemia were also treatable. The unorthodox treatment of Laotil, available at a cancer clinic in Mexico, attracted many patients for whom conventional methods had failed. In the U.S. and Britain there was growing suspicion of industry as a cause of cancer, particularly asbestos and steel production, and legislation was brought in causing many factories to close. In 1981 Professors Richard Peto and Richard Doll drew attention to the relation of diet and smoking to cancer. The programme concludes with an account of the hopes raised by the drug Interferon. This, however, proved to have very limited use in cancer treatment
Halving premature death( Visual )

1 edition published in 2002 in English and held by 1 WorldCat member library worldwide

A prospective study of chronic disease and risk factors in an urban Chinese population by Zheng-Ming Chen( )

1 edition published in 1992 in English and held by 1 WorldCat member library worldwide

Organisation et analyse des essais thérapeutiques comparatifs comportant une longue surveillance des malades( Book )

1 edition published in 1979 in Undetermined and held by 1 WorldCat member library worldwide

We love cigarettes( Visual )

1 edition published in 2006 in English and held by 1 WorldCat member library worldwide

This programme looks at one day in our planet's obsession with the cigarette - we hear from people across the globe about their smoking habits. Quitting guru Allen Carr talks about how he quit smoking 20 years ago and gives a few tips for smokers who want to quit. Jon Ronson and David Hockney defend the pleasures of nicotine. Jed Rose, inventor of the nicotine patch, invites us to watch a test in which someone smokes a radioactive cigarette in an MRI scanner so we can watch the way the nicotine disperses into the body. Sir Richard Peto, who is conducting the longest health study in the history of science by following smokers over many years, describes his work and shows the case files of over 30 000 subjects in his study who have died from smoking-related illnesses. We also meet Chris Proctor and watch his attempts to make a healthy cigarette. Stephen Westaby, heart surgeon, talks us through just some of the negative affects smoking has on the body and we see him operate on a smoking man's heart. Jeffrey Wigand who went against the tobacco industry in the US, and about whom the film 'The Insider' was made, tells his story. And Linda Ferry, an anti-smoking Evangelist who has been running quitting smoking camps for years talks about her discovery of how the drug Zyban can double your chances of quitting
Tobacco : the growing epidemic : proceedings of the tenth World Conference on Tobacco or Health, 24-28 August 1997, Beijing, China by Rushan Lu( Book )

2 editions published in 2000 in English and held by 1 WorldCat member library worldwide

This book contains the full proceedings of the Tenth World Conference on Tobacco or Health, held 24-28 August 1997 in Beijing, China, and hosted by the Chinese Association on Smoking and Health and the Chinese Medical Association. Tobacco is now causing a worldwide epidemic of premature death and disability, affecting first men and then women in developed countries, and now increasingly affecting developing countries. The theme "Tobacco: The Growing Epidemic" was chosen to reflect the increasingly global nature of the problem
Open Forum 08(2000) : the next big thing : defying death by Open University OF08(2000)( Visual )

in English and held by 1 WorldCat member library worldwide

Hans-Jurgen Eysenck by H. J Eysenck( Visual )

1 edition published in 1994 in English and held by 1 WorldCat member library worldwide

Prof. Hans Eysenck's account of his life is intercut with views from his critics and defenders, who discuss his controversial pronouncements on the link between race and intelligence and his latest argument that the connection between smoking and lung cancer is an illusory one. Eysenck's lectures on race and intelligence at the London School of Economics and at Melbourne University in the 1960s were the scene of violent confrontations between the political right-wing, who seized on his arguments, and anti-racists. Eysenck compared the violent protestors to the Nazis who forced him to leave Germany. His critics in this programme include Prof. Steve Jones (University College, London) and Prof. Richard Peto (Oxford University). Adrian Furnham (Prof. of Psychology, University College, London) defends his integrity in holding to his views at the expense of advancement in his career
Halving premature death is it realistic? by Richard Peto( Visual )

1 edition published in 2006 in English and held by 1 WorldCat member library worldwide

10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial by ACST Collaborative Group( )

1 edition published in 2010 in English and held by 1 WorldCat member library worldwide

Background. If carotid artery narrowing remains asymptomatic (ie, has caused no recent stroke or other neurological symptoms), successful carotid endarterectomy (CEA) reduces stroke incidence for some years. We assessed the long-term effects of successful CEA. Methods. Between 1993 and 2003, 3120 asymptomatic patients from 126 centres in 30 countries were allocated equally, by blinded minimised randomisation, to immediate CEA (median delay 1 month, IQR 0.3-2.5) or to indefinite deferral of any carotid procedure, and were followed up until death or for a median among survivors of 9 years (IQR 6-11). The primary outcomes were perioperative mortality and morbidity (death or stroke within 30 days) and non-perioperative stroke. Kaplan-Meier percentages and logrank p values are from intention-to-treat analyses. This study is registered, number ISRCTN26156392. Findings. 1560 patients were allocated immediate CEA versus 1560 allocated deferral of any carotid procedure. The proportions operated on while still asymptomatic were 89.7% versus 4.8% at 1 year (and 92.1% vs 16.5% at 5 years). Perioperative risk of stroke or death within 30 days was 3.0% (95% CI 2.4-3.9; 26 non-disabling strokes plus 34 disabling or fatal perioperative events in 1979 CEAs). Excluding perioperative events and non-stroke mortality, stroke risks (immediate vs deferred CEA) were 4.1% versus 10.0% at 5 years (gain 5.9%, 95% CI 4.0-7.8) and 10.8% versus 16.9% at 10 years (gain 6.1%, 2.7-9.4); ratio of stroke incidence rates 0.54, 95% CI 0.43-0.68, p<0.0001. 62 versus 104 had a disabling or fatal stroke, and 37 versus 84 others had a non-disabling stroke. Combining perioperative events and strokes, net risks were 6.9% versus 10.9% at 5 years (gain 4.1%, 2.0-6.2) and 13.4% versus 17.9% at 10 years (gain 4.6%, 1.2-7.9). Medication was similar in both groups; throughout the study, most were on antithrombotic and antihypertensive therapy. Net benefits were significant both for those on lipid-lowering therapy and for those not, and both for men and for women up to 75 years of age at entry (although not for older patients). Interpretation-Successful CEA for asymptomatic patients younger than 75 years of age reduces 10-year stroke risks. Half this reductionis in disabling or fatal strokes. Net benefit in future patients will depend on their risks from unoperated carotid lesions (which will be reduced by medication), on future surgical risks (which might differ from those in trials), and on whether life expectancy exceeds 10 years
moreShow More Titles
fewerShow Fewer Titles
Audience Level
Audience Level
  Kids General Special  
Audience level: 0.57 (from 0.39 for Hans-Jurge ... to 0.98 for Le cause d ...)

Viral etiology of cervical cancer
Alternative Names
Peto, R. 1943-

Peto, R. (Richard), 1943-

Richard Peto britischer Statistiker und Epidemiologe

Richard Peto Brits epidemioloog

Richard Peto English statistician and epidemiologist

Tobacco : the growing epidemic : proceedings of the tenth World Conference on Tobacco or Health, 24-28 August 1997, Beijing, China